CHRS - Coherus Oncology, Inc. - Options-Kette

Coherus Oncology, Inc.
US ˙ NasdaqGM ˙ US19249H1032

Verfall
Calls für June 03, 2026
Vertrag Streiks Gebot Fragen Letzte Volumen OI IV Delta Gamma Theta Vega Rho
CHRS20260618C00000500 0.50 0.65 1.40 0.00 0 1 0.00% 0.00 0.00 0.00 0.00 0.00
CHRS20260618C00001000 1.00 0.20 0.95 0.00 0 0 211.65% 0.91 0.31 -0.00 0.00 0.00
CHRS20260618C00001500 1.50 0.00 0.75 0.00 0 25 297.33% 0.65 0.43 -0.01 0.00 0.00
CHRS20260618C00002000 2.00 0.00 0.05 0.00 0 185 114.27% 0.16 0.70 -0.00 0.00 0.00
CHRS20260618C00003000 3.00 0.00 0.05 0.00 0 101 216.23% 0.10 0.27 -0.00 0.00 0.00
CHRS20260618C00004000 4.00 0.00 0.05 0.00 0 8 279.20% 0.08 0.18 -0.00 0.00 0.00
CHRS20260618C00005000 5.00 0.00 1.00 0.00 0 0 794.63% 0.55 0.17 -0.03 0.00 0.00
Puts für June 03, 2026
Vertrag Streiks Gebot Fragen Letzte Volumen OI IV Delta Gamma Theta Vega Rho
CHRS20260618P00000500 0.50 0.00 0.05 0.00 0 7 397.41% -0.04 0.07 -0.00 0.00 0.00
CHRS20260618P00001000 1.00 0.00 0.05 0.00 0 0 176.03% -0.09 0.31 -0.00 0.00 -0.00
CHRS20260618P00001500 1.50 0.00 0.25 0.00 0 22 111.80% -0.45 1.27 -0.00 0.00 -0.00
CHRS20260618P00002000 2.00 0.10 0.85 0.00 0 5 424.06% -0.46 0.32 -0.02 0.00 -0.00
CHRS20260618P00003000 3.00 1.10 1.85 0.00 0 0 558.68% -0.52 0.24 -0.02 0.00 -0.00
CHRS20260618P00004000 4.00 2.00 3.00 0.00 0 0 763.09% -0.45 0.17 -0.03 0.00 -0.00
CHRS20260618P00005000 5.00 3.00 4.00 0.00 0 0 821.53% -0.46 0.16 -0.03 0.00 -0.00
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
DE:8C5 1,32 €
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista